Illumina Inc ILMN

Morningstar Rating
€185.80 +6.48 (3.61%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ILMN is trading within a range we consider fairly valued.
Price
€179.32
Fair Value
LOCK|&.LL?cBx
Uncertainty
LOCK|>$?
1-Star Price
LOCK|G.!#Wskp
5-Star Price
LOCK|$.t^@D>D@<
Economic Moat
LOCK|@%P&
Capital Allocation
—

News

Trading Information

Previous Close Price
€179.32
Day Range
€185.80–185.80
52-Week Range
€95.75–269.70
Bid/Ask
€184.36 / €187.22
Shares Outstanding
151.20M
Market Cap
€28.09B
Volume/Avg
— / 2

Key Statistics

Price/Earnings (Normalized)
38.88
Price/Sales
7.06
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
1.16%

Company Profile

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
8,650

Competitors

Valuation

Metric
ILMN
TMO
Price/Earnings (Normalized)
38.8827.78
Price/Book Value
9.834.65
Price/Sales
7.065.42
Price/Cash Flow
24.1924.63
Price/Earnings
ILMN
TMO

Financial Strength

Metric
ILMN
TMO
Quick Ratio
1.791.23
Current Ratio
2.631.81
Interest Coverage
11.485.52
Quick Ratio
ILMN
TMO

Profitability

Metric
ILMN
TMO
Return on Assets (Normalized)
15.38%8.32%
Return on Equity (Normalized)
36.69%17.48%
Return on Invested Capital (Normalized)
20.12%10.45%
Return on Assets
ILMN
TMO

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|zZ<L<<dLOCK|PD$254B
Danaher Corp
DHR
LOCK|Mpb&v^JLOCK|$Vh$159B
IDEXX Laboratories Inc
IDXX
LOCK|J>DnhQ>LOCK|Rr^$54B
Agilent Technologies Inc
A
LOCK|$!%N?rsGLOCK|?!$49B
Waters Corp
WAT
LOCK|C$!$LW@LOCK|>!?$44B
IQVIA Holdings Inc
IQV
LOCK|S^<$Zs!LOCK|s^#W&$42B
Mettler-Toledo International Inc
MTD
LOCK|ThB^!<b>LOCK|wqTL$34B
Illumina Inc
ILMN
LOCK|q#?sPpyLOCK|Pgw<$31B
Labcorp Holdings Inc
LH
LOCK|btpHtFVLOCK|fN<z$$30B
Quest Diagnostics Inc
DGX
LOCK|x@@c#XLOCK|g<N#$28B

Sponsor Center